Showing results (221-230 of 617) with videos related to

Sort By:
Pageof 62
Blood Advances|October 5, 2021
Orthopedic toxicities among adolescents and young adults treated in DFCI ALL Consortium TrialsYannis K Valtis, Kristen E Stevenson, Andrew E Place, et al.
Journal of Thrombosis and Thrombolysis|December 21, 2017
The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemiaRachael F Grace, Daniel J DeAngelo, Kristen E Stevenson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2007
Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantationPhilippe Armand, Haesook T Kim, Daniel J DeAngelo, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2018
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in OncologyJerald P Radich, Michael Deininger, Camille N Abboud, et al.
Haematologica|October 3, 2009
TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsAndrew Chase, Thomas Ernst, Andreas Fiebig, et al.
Seminars in Immunopathology|May 30, 2021
Eosinophils and eosinophil-associated disorders: immunological, clinical, and molecular complexityPeter Valent, Lina Degenfeld-Schonburg, Irina Sadovnik, et al.
Haematologica|January 13, 2010
A polymorphism associated with STAT3 expression and response of chronic myeloid leukemia to interferon αSebastian Kreil, Katherine Waghorn, Thomas Ernst, et al.
Blood|April 26, 2007
Heterogeneous prognostic impact of derivative chromosome 9 deletions in chronic myelogenous leukemiaSebastian Kreil, Markus Pfirrmann, Claudia Haferlach, et al.
Genes, Chromosomes & Cancer|November 14, 2008
Identification of a MYO18A-PDGFRB fusion gene in an eosinophilia-associated atypical myeloproliferative neoplasm with a t(5;17)(q33-34;q11.2)Christoph Walz, Claudia Haferlach, Annette Hänel, et al.
British Journal of Haematology|August 12, 2009
Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin LymphomaMichael Dickinson, David Ritchie, Daniel J DeAngelo, et al.
Pageof 62